Brazil probes vaccine contract with India’s Bharat Biotech

Prosecutors cite the drug's high price, speedy talks and pending regulatory approvals as red flags for the contract.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…